Top Markets
#1 MON MON +2,760.08%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +52.36%
#4 eCash eCash +37.30%
#5 Siren Siren +24.28%
#6 Collector Crypt Collector Crypt +23.96%
#7 PinGo PinGo +23.93%
#8 SAFEcoin SAFEcoin +19.72%
#9 Janction Janction +19.66%
#10 Beldex Beldex +15.26%
Coin of the day
MON MON
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rang în acțiuni #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Preț acțiune
$0.30840035
Capitalizare de piață
$94.37M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-34.60%
Țară
FR
Tranzacționează Sensorion SA (ALSEN)

Categorie

Healthcare
Venituri pentru Sensorion SA (ALSEN)
Venituri în Dec 2025 TTM: $2.73M
Conform celor mai recente rapoarte financiare ale Sensorion SA, venitul actual al companiei (TTM) este $2.73M. În anul 2023, compania a avut un venit de $6.30M o creștere față de venitul din anul 2022, care a fost de $5.29M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Sensorion SA din 2011 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) $2.73M -60.56%
2024 $6.92M 9.91%
2023 $6.30M 19.02%
2022 $5.29M 9.15%
2021 $4.85M 69.26%
2020 $2.86M 3.92%
2019 $2.76M 7.54%
2018 $2.56M 10.42%
2017 $2.32M 12,505.95%
2016 $18.41K -89.23%
2015 $171.03K -38.96%
2014 $280.18K -42.85%
2013 $490.29K 60.42%
2012 $305.63K 1,124,142.32%
2011 $27.19 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $52.05B 1,906,201.38%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.26B 448,772.67%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $14.92B 546,366.42%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.08B 332,560.08%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.29B 230,302.17%
NL